Skip to main content
SpringerLink
Log in
Book cover

Controversies in Radiation Oncology pp 271–277Cite as

Pancreatic Cancer

  • Chapter
  • First Online:

  • 650 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

Pancreatic cancer is an aggressive disease with high rates of disease-related mortality due to high rates of systemic disease spread. The role of radiation therapy for pancreatic cancer has been controversial to date. There have been significant advancements in effective systemic therapy regimens and radiation treatment delivery techniques, however, that are promising. This chapter aims to review all pertinent literature regarding the role of radiation therapy for pancreatic cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abrams RA, Lillemoe KD, Piantadosi S (2001) Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet 358:1565–1566

    Article  CAS  Google Scholar 

  • Chang DT et al (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115:665–672

    Article  Google Scholar 

  • Chauffert B et al (2008) Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol 19:1592–1599

    Article  CAS  Google Scholar 

  • Chuong MD et al (2013) Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 86:516–522

    Article  Google Scholar 

  • Cohen SJ et al (2005) A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys 62:1345–1350

    Article  CAS  Google Scholar 

  • Crane CH, Willett CG (2009) Stereotactic radiotherapy for pancreatic cancer? Cancer 115:468–472

    Article  Google Scholar 

  • Crane CH et al (2011) Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 29:3037–3043

    Article  CAS  Google Scholar 

  • Didolkar MS et al (2010) Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. J Gastrointest Surg 14:1547–1559

    Article  Google Scholar 

  • Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60:2284–2303

    Article  CAS  Google Scholar 

  • Hammel P, Huguet F, Van Laethem J-L, Goldstein D, Glimelius B (2013) Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: final results of the international phase III LAP 07 study. J Clin Oncol 31(18 suppl):LBA4003a. (201AD)

    Article  Google Scholar 

  • Hoyer M et al (2005) Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol J Eur Soc Ther Radiol Oncol 76:48–53

    Article  Google Scholar 

  • Huguet F, Girard N, Guerche CS et al (2009) Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. J Clin Oncol 27(13):2269

    Article  CAS  Google Scholar 

  • Huguet F et al (2007) Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25:326–331

    Article  CAS  Google Scholar 

  • Iacobuzio-Donahue CA et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27:1806–1813

    Article  CAS  Google Scholar 

  • Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903

    Article  CAS  Google Scholar 

  • Klinkenbijl JH et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776–782.; discussion 782–784

    Article  CAS  Google Scholar 

  • Koong AC et al (2005) Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63:320–323

    Article  Google Scholar 

  • Loehrer PJ et al (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol 29:4105–4112

    Article  CAS  Google Scholar 

  • Mahadevan A et al (2010) Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 78:735–742

    Article  Google Scholar 

  • Mahadevan A et al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81:e615–e622

    Article  CAS  Google Scholar 

  • Moertel CG et al (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer 48:1705–1710

    Article  CAS  Google Scholar 

  • Neoptolemos JP et al (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358:1576–1585

    Article  CAS  Google Scholar 

  • Neoptolemos JP et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

    Article  CAS  Google Scholar 

  • Nitecki SS, Sarr MG, Colby TV, van Heerden JA (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66

    Article  CAS  Google Scholar 

  • Piorkowski RJ et al (1982) Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg 143:189–193

    Article  CAS  Google Scholar 

  • Polistina F et al (2010) Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Ann Surg Oncol 17:2092–2101

    Article  Google Scholar 

  • Regine WF et al (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299:1019–1026

    Article  CAS  Google Scholar 

  • Schellenberg D et al (2008) Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 72:678–686

    Article  CAS  Google Scholar 

  • Schellenberg D et al (2011) Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 81:181–188

    Article  Google Scholar 

  • Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29

    Article  Google Scholar 

  • Tempero MA et al (2014) Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 12:1083–1093

    Article  CAS  Google Scholar 

  • Tepper J, Nardi G, Sutt H (1976) Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer 37:1519–1524

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California, Los Angeles, Los Angeles, CA, USA

    Ann Raldow M.D., M.P.H.

  2. Massachusetts General Hospital, Boston, MA, USA

    Jennifer Wo M.D.

Authors
  1. Ann Raldow M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Wo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer Wo M.D. .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA, USA

    Simon S. Lo

  2. Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA

    Bin S. Teh

  3. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

    Guo-Liang Jiang

  4. Department of Radiation Oncology, University of Washington, Seattle, WA, USA

    Nina A. Mayr

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Raldow, A., Wo, J. (2018). Pancreatic Cancer. In: Lo, S., Teh, B., Jiang, GL., Mayr, N. (eds) Controversies in Radiation Oncology. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2018_176

Download citation

  • DOI: https://doi.org/10.1007/174_2018_176

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51194-8

  • Online ISBN: 978-3-319-51196-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation